Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Patheon Completes Acquisition of Manufacturing Site from Roche

By Patheon N.V | February 1, 2017

Patheon adds 300,000 sq ft state-of-the-art manufacturing site in Florence, SC to its global network. (Credit: Business Wire)

Patheon announces completion of its acquisition of state-of-the-art manufacturing site.

Patheon N.V., a global provider of high-quality drug development and delivery for the pharmaceutical and biopharma sectors, announced that it has completed the acquisition of a state-of-the-art manufacturing facility in Florence, SC from Roche Holdings, Inc. Patheon has begun integrating the site into the Patheon network.

The site adds a 300,000 square-foot facility with manufacturing capacity for active pharmaceutical ingredient (API) ranging from development to manufacturing services. With the addition of this site, the company expands its capacity for manufacturing highly potent compounds, adds capabilities to support solid state chemistry, micronization (small & large) and future commercial spray drying.

“We are extremely pleased to add this facility to the Patheon network and the talented professionals that will support a wide range of drug substance services,” said Lukas Utiger, president of Drug Substance Services for Patheon. “Patheon has extensive experience and success integrating new sites into our global network and quickly leveraging the capabilities for the benefit of our clients.”

The new Patheon acquisition is a state-of-the-art pharmaceutical manufacturing facility. In its production space it features reactors ranging from 50-11,000 liters producing multiple products simultaneously, fully compliant to all applicable regulations, fully validated to meet the most stringent production, quality, cGMP (current Good Manufacturing Practices), safety and environmental standards. The site also provides highly flexible operations allowing the company to adapt quickly to new production needs and with capabilities in small and large scale manufacturing.

The site will serve as Patheon’s flagship U.S. API operation for commercial scale and mid-scale API production, and will also enhance Patheon’s emerging pharma presence in the U.S. market. This acquisition is the sixth in the last five years and supports the company’s plans to create the only integrated, end-to-end provider of pharma development and manufacturing services.

(Source: Business Wire)

Related Articles Read More >

Sandoz Logo 2025
Sandoz breaks ground on biosimilar plant in Slovenia
Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
Prolific Machines logo.
Prolific Machines enters FDA program to enhance therapeutics manufacturing platform
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE